Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Dow Chemical, Arcadia Tie Up To Develop Wheat Traits

Published 08/08/2017, 10:05 PM
Updated 07/09/2023, 06:31 AM
Dow Chemical’s (NYSE:DOW) fully-owned subsidiary, Dow AgroSciences LLC and Arcadia Biosciences, Inc. has collaborated to develop and commercialize a breakthrough improved wheat quality trait in North America. The partnership will capitalize on Arcadia’s leading non-GM Tilling trait development platform along with Dow AgroSciences’ enabling technology platforms, high-quality elite germplasm and global commercial channels.

Per the agreement, both companies will further develop and commercialize an improved wheat quality trait which has completed initial field trials and is advancing to next-stage trials. Dow AgroSciences will introgress Arcadia’s trait into its proprietary elite germplasm lines and manage all aspects associated with the commercialization of the traits.
Dow has underperformed the industry it belongs to over the last three months. The company’s shares have moved up around 2.8% over this period, compared with roughly 4.1% gain recorded by the industry.
Dow is witnessing improved global economic activity with strong momentum in manufacturing, investment and trade. While strength of the consumer is driving expansion in the U.S., improvement in Europe is expected to remain on a steady track. The company is also seeing signs of stabilization in Latin America, especially in the agriculture market. Dow also believes that it is well positioned to capture demand in consumer-led markets.
The company is expected to gain from its focus on consumer-led markets and its strategic investments in the U.S. Gulf Coast and the Middle East. Dow should also benefit from its productivity management actions and cost synergies associated with Dow Corning Silicones business. The planned merger with DuPont (NYSE:DD) is also expected to create significant synergies.

Dow Chemical Company (The) Price and Consensus

Dow Chemical Company (The) Price and Consensus | Dow Chemical Company (The) Quote

Dow Chemical currently carries a Zacks Rank #3 (Hold).

Stocks to Consider

Some better-ranked companies in the chemical space include Arkema S.A. (OTC:ARKAY) and Kronos Worldwide (NYSE:KRO) . Both the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Arkema has an expected long-term earnings growth of 12.8%.

Kronos Worldwide has an expected long-term earnings growth of 5%.

More Stock News: Tech Opportunity Worth $386 Billion in 2017

From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.

Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>



E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report

Dow Chemical Company (The) (DOW): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

Arkema SA (ARKAY): Free Stock Analysis Report

Original post
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.